Name: Complete 3-in-1 kit for Fentanyl/Xylazine/Nitazene test, for forensic and harm reduction applications
SKU: KFXN25
Availability: InStock

Order through Avantor/VWR: Box of 25

Product Overview

The Instanosis Complete Fentanyl, Xylazine, and Nitazene 3-in-1 Test Kit is a premier multiplexed lateral flow immunoassay manufactured in the USA for forensic and harm reduction applications. This advanced combo screening panel simultaneously detects three critical synthetic adulterants—Fentanyl (2 ng/mL), Xylazine (10 ng/mL), and Nitazenes (50 ng/mL)—from a single micro-volume sample. Requiring 90% less sample amount than standard market alternatives, it delivers precise qualitative visual results in 5 minutes, significantly streamlining polysubstance drug-checking workflows while maximizing primary compound preservation for laboratory confirmation. The kit contains one multiplexed test strip individually packed in a plastic pouch, one cotton swab, one plastic dropper, one sample vial and an instruction to use.

Technical Specifications & Key Data

This multiplexed lateral flow immunoassay provides high-affinity, simultaneous profiling for the three most critical adulterant classes currently impacting the unregulated supply chain:

Simultaneous 3-in-1 Detection Profile:
- Fentanyl: 2 ng/mL analytical cut-off.
- Xylazine: 10 ng/mL analytical cut-off.
- Nitazenes: 50 ng/mL analytical cut-off (cross-reactive with prominent benzimidazole analogs like metonitazene and isotonitazene).
Micro-Volume Processing: Requires 90% less sample amount (1/10th of competitive baseline requirements), ensuring critical primary compounds remain intact for confirmatory testing.
Assay Performance Window: Clear, reliable qualitative visual results in 5 minutes.
Origin & Quality Standards: Developed under rigorous quality frameworks and proudly Made in the U.S in an FDA registered manufacturing facility compliant with FDA QMSR.

Public Health & Toxicological Significance

The modern illicit drug supply is heavily dominated by complex polysubstance configurations, making individual single-strip testing inefficient for comprehensive public health surveillance.

Fentanyl Core Hazard: Highly lethal synthetic opioid requiring rapid, ultra-sensitive field tracking to prevent fatal respiratory arrest.
Xylazine Co-Adulteration: A non-opioid veterinary sedative (“tranq”) frequently mixed with fentanyl to prolong its effects, known to cause severe necrotic skin ulcerations and profound hypotension.
The Nitazene Threat: Benzimidazole synthetic opioids exhibiting structural potencies up to 10 times greater than fentanyl, frequently added to counterfeit pills and missed entirely by standalone fentanyl screens.
Impact on Overdose: Because both xylazine and nitazenes introduce profound non-opioid or ultra-high affinity receptor interactions, overdoses involving these multi-substance mixtures frequently manifest with rapid-onset respiratory failure.

Ordering Options & Channel Availability

Institutional Procurement: Municipal and state health departments and university research labs can order from this website or primary scientific distribution catalogs such Avantor / VWR (link above Product Overview).

Frequently Asked Questions (FAQ)

Q1: What specific adulterants does this 3-in-1 combo kit screen for simultaneously?

A: This multiplexed kit provides independent visual lines to simultaneously identify Fentanyl, Xylazine and the Benzimidazole (Nitazene) synthetic opioid family from a single preparation.

Q2: What are the exact analytical cut-off limits for each drug?

A: The technical limits of detection are calibrated at an ultra-sensitive 2 ng/mL for Fentanyl, 10 ng/mL for Xylazine, and 50 ng/mL for Nitazenes, maximizing cross-reactivity across shifting illicit chemical structures.

Q3: Why is the micro-volume sample requirement an advantage?

A: Because this assay requires 1/10th of the sample amount typically demanded by standard competitor strips, public health teams and forensic technicians can execute full polysubstance checking while preserving nearly the entire primary sample for confirmatory laboratory analysis.

Q4: Can standard fentanyl test strips detect the nitazene component found in this kit?

A: No. Nitazenes are chemically distinct benzimidazole compounds and entirely lack the molecular core structure of fentanyl. Standard fentanyl test strips will completely miss them, making this combined multiplex strip essential for accurate risk reduction.

Q5: Is this multiplexed testing kit manufactured in the United States?

A: Yes. The Instanosis complete 3-in-1 test kit is developed and manufactured entirely in the USA in an FDA registered manufacturing facility compliant with FDA QMSR.

Q6: Can corporate or state agencies procure this kit through standard laboratory distributors?

A: Yes. In addition to direct corporate purchasing accounts, procurement departments can order the Instanosis Box of 25 tests through our established distribution product listings across primary scientific networks such as Avantor/VWR.